NEW YORK and TOKYO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) ("HeartCore" or the "Company"), an IPO consulting services company based in Tokyo, reported financial results for the second quarter ended June 30, 2026.
Recent Operational Highlights
-- As of June 30, 2026, HeartCore was engaged with 16 Go IPO clients,
including 6 clients currently in various stages of preparation for
potential initial public offerings and U.S. exchange listings.
-- Entered into an agreement with Luvina Software Joint Stock Company to
divest the Company's 51% equity interest in HeartCore Luvina Vietnam
Company Limited ("HeartCore Luvina") as part of ongoing portfolio
optimization.
-- Completed the strategic divestiture of Sigmaways, Inc. ("Sigmaways"),
concentrating the Company's business on Go IPO consulting, capital
markets advisory, and financial services.
-- Regained compliance with the $1.00 minimum bid price requirement set
forth in Nasdaq Listing Rule 5550(a)(2).
Management Commentary
HeartCore CEO Sumitaka Kanno commented: "During the first half of 2026, we took decisive steps to simplify HeartCore's operating structure and sharpen our strategic focus. The divestiture of Sigmaways and the pending disposition of our 51% equity interest in HeartCore Luvina Vietnam represent important components of our ongoing portfolio optimization and will allow us to further concentrate resources on our core Go IPO and planned launch of our financial services business. The Nasdaq listing environment remains selective and compliance-driven, reinforcing the importance of disciplined client selection and thorough preparation. Accordingly, we are prioritizing opportunities with clients that we believe demonstrate stronger fundamentals, organizational readiness, and a clear path toward satisfying U.S. regulatory and exchange-listing requirements. With a streamlined portfolio and a more focused pipeline, we believe HeartCore is better positioned to deepen client relationships and advance its capital markets and financial services initiatives."
Second Quarter 2026 Financial Results
Revenues increased by 71.6% to $321,000, compared to $187,000 in the same period last year. The increase was primarily due to an increase in software development services revenue in connection with additional customer orders obtained by HeartCore Luvina, the Company's Vietnamese subsidiary, partially offset by a decrease in Go IPO consulting services revenue primarily due to fewer Go IPO customers and extensions of IPO timelines by IPO customers during the current period.
Gross loss was $70,000, compared to gross loss of $23,000 in the same period last year. The increase in gross loss was primarily due to a decrease in gross profit from Go IPO consulting services, as the Company devoted additional efforts and resources, and incurred more outsourcing expenses, to enhance its Go IPO consulting customer experience, partially offset by an increase in gross profit from software development services in light of the increase in sales.
Operating expenses were $754,000, compared to $745,000 in the same period last year. The increase was primarily due to an increase in general and administrative expenses, partially offset by a decrease in selling expenses.
Net loss was $2.0 million, compared to net income of $1.1 million in the same period last year, as a result of the aforementioned increase in gross loss, a shift from other income to other expenses, and a loss from discontinued operations.
Adjusted EBITDA was $(1.3) million for the second quarter of 2026, compared to Adjusted EBITDA of $(0.1) million in the same period last year.
Six Months Ended June 30, 2026 Financial Results
Revenues increased by 25.9% to $554,000 for the first six months of 2026, compared to $440,000 in the same period last year. The increase was primarily due to an increase in software development services revenue in connection with additional customer orders obtained by HeartCore Luvina, partially offset by a decrease in Go IPO consulting services revenue primarily due to fewer Go IPO customers and extensions of IPO timelines by IPO customers during the current period.
Gross loss was $178,000, compared to gross profit of $75,000 in the same period last year. The decline in gross profit was primarily due to a decrease in gross profit from Go IPO consulting services, as the Company devoted additional efforts and resources to enhance its Go IPO consulting customer experience, resulting in a gross loss from Go IPO consulting services, partially offset by an increase in gross profit from software development services in light of the increase in sales.
Operating expenses were $2.0 million, compared to $1.9 million in the same period last year. The increase was primarily due to an increase in general and administrative expenses, partially offset by a decrease in selling expenses.
Net loss was $4.0 million, compared to a net loss of $2.1 million in the same period last year, as a result of the aforementioned decrease in gross profit, an increase in other expenses, and a loss from discontinued operations.
Adjusted EBITDA was $(2.9) million for the six months ended June 30, 2026, compared to Adjusted EBITDA of $(1.2) million in the same period last year.
As of June 30, 2026, the Company had cash and cash equivalents of $587,000.
About HeartCore Enterprises, Inc.
HeartCore Enterprises, Inc. is headquartered in Tokyo, Japan, and is a leading consulting services company providing U.S. market listing support and related advisory services primarily to Japanese corporate clients. For more information, please visit https://heartcore-enterprises.com/.
Non-GAAP Financial Measures
This document includes references to Adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, Adjusted EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, changes in fair value of derivative liability, interest income, interest expenses, other income, and other expenses.
This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the U.S. ("GAAP").
Management believes that Adjusted EBITDA provides useful information to investors by highlighting the Company's core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.
For the six months ended June 30,
Item 2026 2025
---------------------------------------------- -------------- --------------
Net loss ($4.0) million ($2.1) million
---------------------------------------------- -------------- --------------
(+) Depreciation $0.0 million $0.0 million
---------------------------------------------- -------------- --------------
(+) Changes in fair value of investments in
marketable securities $0.8 million $0.9 million
---------------------------------------------- -------------- --------------
(+) Changes in fair value of investment in
warrants $0.0 million ($0.1) million
---------------------------------------------- -------------- --------------
(+) Changes in fair value of derivative
liability ($0.0) million $0.0 million
---------------------------------------------- -------------- --------------
(+) Interest income ($0.0) million ($0.0) million
---------------------------------------------- -------------- --------------
(+) Interest expenses $0.0 million $0.0 million
---------------------------------------------- -------------- --------------
(+) Other income ($0.0) million ($0.0) million
---------------------------------------------- -------------- --------------
(+) Other expenses $0.3 million $0.0 million
---------------------------------------------- -------------- --------------
Adjusted EBITDA ($2.9) million ($1.2) million
---------------------------------------------- -------------- --------------
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as "believed," "intend," "expect," "anticipate," "plan," "potential," "continue," or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore's filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore's control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking
statement reflects HeartCore's current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.
HeartCore Investor Relations Contact:
Gateway Group, Inc.
John Yi and Steven Shinmachi
HTCR@gateway-grp.com
(949) 574-3860
HEARTCORE ENTERPRISES, INC.
CONSOLIDATED BALANCE SHEETS
June 30, December 31,
2026 2025
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 587,074 $ 1,904,826
Accounts receivable 62,770 22,830
Investments in marketable securities 2,668,317 3,690,187
Prepaid expenses 114,340 127,565
Deferred offering costs 250,000 250,000
Other current assets 113,670 208,503
Current assets of discontinued
operations - 920,683
Proceeds receivable from sale of
discontinued operations 467,970 1,291,298
Total current assets 4,264,141 8,415,892
Non-current assets:
Property and equipment, net 252,389 275,465
Operating lease right-of-use assets 412,976 17,781
Long-term investment in warrants 121,774 280,924
Deferred tax assets 22,286 23,121
Security deposits 270,525 281,313
Other non-current assets 816 549
Non-current assets of discontinued
operations - 29,437
Long-term proceeds receivable from
sale of discontinued operations 3,520,918 3,736,995
Total non-current assets 4,601,684 4,645,585
Total assets $ 8,865,825 $ 13,061,477
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses $ 286,711 $ 299,042
Accounts payable and accrued expenses
- related party 33,946 124,618
Accrued payroll and other employee
costs 88,057 64,203
Due to related party 460 285
Insurance premium financing 66,327 13,430
Operating lease liabilities, current 280,326 17,781
Income tax payables 1,737,804 1,857,386
Deferred revenue 568,773 676,216
Derivative liability 74,461 121,719
Other current liabilities 523,236 526,984
Current liabilities of discontinued
operations - 1,628,586
Total current liabilities 3,660,101 5,330,250
Non-current liabilities:
Operating lease liabilities,
non-current 139,094 -
Non-current liabilities of
discontinued operations - 448,376
Total non-current liabilities 139,094 448,376
----------- -----------
Total liabilities 3,799,195 5,778,626
Shareholders' equity:
Preferred shares, $0.0001 par value,
20,000,000 shares authorized; Series
A convertible preferred shares,
4,000 shares designated, 617 and
1,017 shares issued and outstanding
as of June 30, 2026 and December 31,
2025, respectively; aggregate
liquidation preference of $748,228
and $1,158,362 as of June 30, 2026
and December 31, 2025, respectively 419,741 691,858
Common shares, $0.0001 par value,
200,000,000 shares authorized,
1,441,565 and 1,270,991 shares
issued and outstanding as of June
30, 2026 and December 31, 2025,
respectively* 144 127
Additional paid-in capital 22,128,976 21,902,169
Accumulated deficit (17,650,321) (13,755,534)
Accumulated other comprehensive loss (2,702) (58,497)
Total HeartCore Enterprises, Inc.
shareholders' equity 4,895,838 8,780,123
Non-controlling interests 170,792 (1,497,272)
Total shareholders' equity 5,066,630 7,282,851
----------- -----------
Total liabilities and shareholders'
equity $ 8,865,825 $ 13,061,477
HEARTCORE ENTERPRISES, INC.
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME (LOSS)
For the Six Months
Ended June 30,
---------------------------
2026 2025
----------- -------------
Revenues $ 553,926 $ 439,909
Cost of revenues (including cost of
revenues resulting from transactions
with a related party of $151,143 and
$265,678 for the three and six months
ended June 30, 2026, respectively, and
of $31,328 and $56,523 for the three
and six months ended June 30, 2025,
respectively) 732,056 365,142
---------- ----------
Gross profit (loss) (178,130) 74,767
Operating expenses:
Selling expenses 69,203 214,596
General and administrative expenses
(including general and
administrative expenses resulting
from transactions with a related
party of nil for the three and six
months ended June 30, 2026, and of
$11,433 and $29,048 for the three
and six months ended June 30, 2025,
respectively) 1,888,888 1,708,906
Total operating expenses 1,958,091 1,923,502
---------- ----------
Loss from continuing operations (2,136,221) (1,848,735)
---------- ----------
Other income (expenses):
Changes in fair value of investments
in marketable securities (817,491) (928,955)
Changes in fair value of investment
in warrants (16,635) 72,660
Changes in fair value of derivative
liability 47,258 -
Interest income 601 3,444
Interest expenses (4,477) (5,874)
Other income 31,181 22,995
Other expenses (349,386) (913)
----------
Total other income (expenses) (1,108,949) (836,643)
---------- ----------
Income (loss) from continuing operations
before income tax expense (3,245,170) (2,685,378)
---------- ----------
Income tax expense 38,341 45,581
---------- ----------
Net income (loss) from continuing
operations (3,283,511) (2,730,959)
Income (loss) from discontinued
operations, net of income tax (732,723) 655,084
---------- ----------
Net income (loss) (4,016,234) (2,075,875)
Less: net income from continuing
operations attributable to
non-controlling interests 30,074 18,888
Less: loss from discontinued operations
attributable to non-controlling
interests (151,521) (107,673)
---------- ----------
Net income (loss) attributable to
HeartCore Enterprises, Inc. (3,894,787) (1,987,090)
Dividends accrued on Series A
convertible preferred shares (47,324) (611)
---------- ----------
Net income (loss) attributable to
HeartCore Enterprises, Inc. common
shareholders $(3,942,111) $(1,987,701)
========== ==========
Other comprehensive income (loss):
Foreign currency translation
adjustment (34,513) 48,038
---------- ----------
Total comprehensive income (loss) (4,050,747) (2,027,837)
Less: comprehensive loss attributable
to non-controlling interests (130,384) (89,935)
---------- ----------
Comprehensive income (loss)
attributable to HeartCore Enterprises,
Inc. $(3,920,363) $(1,937,902)
========== ==========
Net income (loss) from continuing
operations attributable to HeartCore
Enterprises, Inc. per common share*
Basic $ (2.51) $ (2.49)
========== ==========
Diluted $ (2.51) $ (2.49)
========== ==========
Income (loss) from discontinued
operations per common share*
Basic $ (0.43) $ 0.69
========== ==========
Diluted $ (0.43) $ 0.69
========== ==========
Net income (loss) attributable to HeartCore
Enterprises, Inc. per common share*
Basic $ (2.94) $ (1.80)
========== ==========
Diluted $ (2.94) $ (1.80)
========== ==========
Weighted average common shares
outstanding*
Basic 1,341,297 1,103,617
========== ==========
Diluted 1,341,297 1,105,245
========== ==========
HEARTCORE ENTERPRISES, INC.
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Six Months
Ended June 30,
---------------------------
2026 2025
----------- -------------
Cash flows from operating activities of
continuing operations:
Net loss $(4,016,234) $(2,075,875)
Income (loss) from discontinued
operations, net of income tax (732,723) 655,084
---------- ----------
Net loss from continuing operations (3,283,511) (2,730,959)
Adjustments to reconcile net loss from
continuing operations to net cash flows
used in operating activities of
continuing operations:
Depreciation expense 15,394 28,728
Loss on disposal of property and
equipment - 116,981
Non-cash lease expense 133,553 30,620
Gain on termination of lease - (9,059)
Deferred income taxes - 27,673
Stock-based compensation 2,031 60,204
Changes in fair value of investments
in marketable securities 817,491 928,955
Changes in fair value of investment
in warrants 16,635 (72,660)
Changes in fair value of derivative
liability (47,258) -
Gain on settlement of asset
retirement obligations - (45,873)
Changes in assets and liabilities:
Accounts receivable (40,102) (30,439)
Prepaid expenses 120,260 60,557
Other assets 83,271 152,927
Accounts payable and accrued expenses (9,464) (106,918)
Accounts payable and accrued expenses
- related party (90,717) (23,386)
Accrued payroll and other employee
costs 25,945 (35,053)
Due to related party 191 (884)
Operating lease liabilities (126,904) (23,648)
Income tax payables 11,150 (105,946)
Deferred revenue (107,443) (190,163)
Other liabilities (3,278) 2,865
----------
Net cash flows used in operating
activities of continuing operations (2,482,756) (1,965,478)
Cash flows from investing activities of
continuing operations:
Purchases of property and equipment (1,840) -
Proceeds from sale of marketable
securities 346,894 1,071,732
Net cash flows provided by investing
activities of continuing operations 345,054 1,071,732
Cash flows from financing activities of
continuing operations:
Payments for finance lease - (8,375)
Repayment of insurance premium
financing (55,103) (65,257)
Proceeds from issuance of common shares
related to at the market offering
agreement - 30,445
Proceeds from collection of
subscription receivable - 103,942
Proceeds from exercise of stock options - 117,000
Proceeds from issuance of Series A
convertible preferred shares and
common shares related to securities
purchase agreement, net of share
issuance costs - 1,800,000
Net cash flows provided by (used in)
financing activities of continuing
operations (55,103) 1,977,755
Cash flows from discontinued
operations:
Net cash flows used in operating
activities of discontinued operations (11,397) (709,414)
Net cash flows provided by investing
activities of discontinued operations 844,198 19,904
Net cash flows used in financing
activities of discontinued operations (22,134) (206,988)
---------- ----------
Net cash flows provided by (used in)
discontinued operations 810,667 (896,498)
Effect of exchange rate changes (16,750) 39,022
Net change in cash and cash equivalents (1,398,888) 226,533
Cash and cash equivalents - beginning
of the period 1,985,962 2,121,089
Cash and cash equivalents - end of the
period $ 587,074 $ 2,347,622
========== ==========
Supplemental cash flow disclosures:
Interest paid $ 30,674 $ 63,320
========== ==========
Income taxes paid (received), net $ (17,394) $ 131,118
========== ==========
Non-cash investing and financing
transactions:
Insurance premium financing $ 108,000 $ 139,500
========== ==========
Warrants converted to marketable
securities $ 142,515 $ -
========== ==========
Operating lease right-of-use assets
obtained in exchange for operating
lease liabilities $ 552,577 $ 23,495
========== ==========
Dividends accrued on Series A
convertible preferred shares $ 47,324 $ 611
========== ==========
Series A convertible preferred shares
converted to common shares $ 272,117 $ -
==========
Issuance of common shares related to
equity purchase agreement $ - $ 250,000
========== ==========